Beijing Weici Technology

The firm develops and provides weak magnetic field device solutions, with a significant focus on creating high-end medical equipment for biomagnetic imaging. This positions the company in the diagnostic equipment industry. A primary product is a liquid-free helium magnetocardiography device that detects weak magnetic fields for large-scale cardiovascular functional imaging. The objective is to introduce a non-superconducting magnetic heart scan imager in China to facilitate the early diagnosis of heart disease and the rapid triage of adult chest pain. This technology is also intended for applications such as screening for fetal congenital heart disease.

Beyond cardiovascular applications, Beijing Weici Technology is developing fully integrated, liquid-helium-free magnetoencephalography (MEG) systems. These systems are designed to be a new tool for brain science, brain-computer interfaces, and research into brain diseases. The MEG systems feature high-sensitivity detectors, high-precision background magnetic field control, and system integration with stimulus systems like visual and auditory tools. The company has been involved in significant milestones, including the release of a 256-channel liquid-helium-free MEG system and the installation of a 64-channel version at Beijing Anzhen Hospital. This technology has been used in pioneering surgical procedures, such as for refractory epilepsy and glioma resection, supported by national research and development plans.